Glycolysis as primary energy source in tumor cell chemotaxis
- PMID: 2174462
- DOI: 10.1093/jnci/82.23.1836
Glycolysis as primary energy source in tumor cell chemotaxis
Abstract
The energy requirements via glycolytic pathways were directly measured in migrating tumor cells. Motility in the metastatic human melanoma cell line A2058, stimulated by insulinlike growth factor I (IGF-I), depends on glycolysis in the presence of glucose as its principal source of energy. Motility in glucose-free medium was 75% reduced and utilized mitochondrial respiration (inhibited by oligomycin). With increasing (physiologic) glucose concentrations, there was a dramatic shift to anaerobic glycolysis as the energy source and 93% elimination of the oligomycin inhibition of motility. Oxamate, an inhibitor of glycolysis, inhibited motility at all glucose concentrations. CO2 production from glycolysis and from the hexose monophosphate shunt was measured in migrating tumor cells. The time course and glucose-dose dependence of glycolytic CO2 production correlated directly with motility. In contrast, mitochondrial CO2 production was inversely related to glucose concentration. A monoclonal antibody for the IGF-I receptor inhibited both motility and glycolytic CO2 production, indicating that both processes are receptor mediated.
Similar articles
-
Hypersensitization of tumor cells to glycolytic inhibitors.Biochemistry. 2001 May 8;40(18):5542-7. doi: 10.1021/bi002426w. Biochemistry. 2001. PMID: 11331019
-
Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3221-3236. doi: 10.1016/j.bbagen.2016.08.006. Epub 2016 Aug 16. Biochim Biophys Acta Gen Subj. 2017. PMID: 27538376
-
Modification of tumour glucose metabolism for therapeutic benefit.Acta Oncol. 1995;34(3):429-33. doi: 10.3109/02841869509094003. Acta Oncol. 1995. PMID: 7779436
-
Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis.J Cereb Blood Flow Metab. 2007 Feb;27(2):219-49. doi: 10.1038/sj.jcbfm.9600343. Epub 2006 Jul 12. J Cereb Blood Flow Metab. 2007. PMID: 16835632 Review.
-
Does the oxidative/glycolytic ratio determine proliferation or death in immune recognition?Ann N Y Acad Sci. 1999;887:77-82. doi: 10.1111/j.1749-6632.1999.tb07923.x. Ann N Y Acad Sci. 1999. PMID: 10668465 Review.
Cited by
-
Immunohistochemical studies of vascular volume and proliferative activity in squamous cell carcinoma of the esophagus.Surg Today. 1997;27(2):99-106. doi: 10.1007/BF02385896. Surg Today. 1997. PMID: 9017984
-
The angiogenic switch leads to a metabolic shift in human glioblastoma.Neuro Oncol. 2017 Mar 1;19(3):383-393. doi: 10.1093/neuonc/now175. Neuro Oncol. 2017. PMID: 27591677 Free PMC article.
-
Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells.J Bioenerg Biomembr. 2011 Oct;43(5):507-18. doi: 10.1007/s10863-011-9375-2. Epub 2011 Jul 21. J Bioenerg Biomembr. 2011. PMID: 21833601
-
The glycolytic enzyme phosphofructokinase-1 assembles into filaments.J Cell Biol. 2017 Aug 7;216(8):2305-2313. doi: 10.1083/jcb.201701084. Epub 2017 Jun 23. J Cell Biol. 2017. PMID: 28646105 Free PMC article.
-
Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer.PeerJ. 2018 Nov 9;6:e5917. doi: 10.7717/peerj.5917. eCollection 2018. PeerJ. 2018. PMID: 30515357 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical